Speaker Detail View
Guangqing Xiao has completed his Ph.D from Boston University and postdoctoral studies from University of California at San Francisco, School of Pharmacy. He is the director of DMPK at Sunovion Pharmaceuticals Inc.
- He has published more than 25 papers in reputed journals and repute. A highly motivated, well-organized, and technically proficient scientist with over fifteen year’s experience in drug discovery and development. Experience in ADME, DDI, PK/PD modeling using Phoenix & SimCYP, human PK & dose projection for both small molecules and biologics. Ph.D. in Biochemistry & Cell Biology, and Postdoctoral training in drug transporters.